MindBio Therapeutics Corp. (CSE: MBIO)

MindBio Therapeutics Statistics

Total Valuation

MindBio Therapeutics has a market cap or net worth of CAD 2.86 million. The enterprise value is 7.24 million.

Market Cap	2.86M
Enterprise Value	7.24M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MindBio Therapeutics has 142.96 million shares outstanding. The number of shares has increased by 4.59% in one year.

Current Share Class	n/a
Shares Outstanding	142.96M
Shares Change (YoY)	+4.59%
Shares Change (QoQ)	-2.21%
Owned by Insiders (%)	5.44%
Owned by Institutions (%)	n/a
Float	127.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.26
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-335.40%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	51.05
Average Volume (20 Days)	89,758

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MindBio Therapeutics had revenue of CAD -175,792 and -545,750 in losses. Loss per share was -0.00.

Revenue	-175,792
Gross Profit	-175,792
Operating Income	-696,767
Pretax Income	-549,079
Net Income	-545,750
EBITDA	n/a
EBIT	-696,767
Loss Per Share	-0.00

Balance Sheet

The company has 66,902 in cash and 4.49 million in debt, giving a net cash position of -4.43 million or -0.03 per share.

Cash & Cash Equivalents	66,902
Total Debt	4.49M
Net Cash	-4.43M
Net Cash Per Share	-0.03
Equity (Book Value)	-5.31M
Book Value Per Share	-0.04
Working Capital	-5.03M

Cash Flow

Operating Cash Flow	-90,752
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	396.36%
Pretax Margin	312.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MindBio Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.59%
Shareholder Yield	-4.59%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MindBio Therapeutics has an Altman Z-Score of -195.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-195.25
Piotroski F-Score	n/a